This report aims to provide a comprehensive presentation of the global market for Injectable Drug Delivery Formulation, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Injectable Drug Delivery Formulation. This report contains market size and forecasts of Injectable Drug Delivery Formulation in global, including the following market information:
Global Injectable Drug Delivery Formulation Market Revenue, 2018-2023, 2024-2030, ($ millions)
Global Injectable Drug Delivery Formulation Market Sales, 2018-2023, 2024-2030, (K Pcs)
Global top five Injectable Drug Delivery Formulation companies in 2022 (%)
The global Injectable Drug Delivery Formulation market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million.
Conventional Drug Delivery Formulations Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Injectable Drug Delivery Formulation include Becton, Dickinson and Company (US), Baxter International Inc. (US), Gerresheimer AG (Germany), Pfizer, Inc. (US), Schott AG (Germany), Sandoz (Germany), Teva Pharmaceutical Industries Ltd. (Israel) and Eli Lilly and Company (US), etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Injectable Drug Delivery Formulation manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Injectable Drug Delivery Formulation Market, by Type, 2018-2023, 2024-2030 ($ Millions) & (K Pcs)
Global Injectable Drug Delivery Formulation Market Segment Percentages, by Type, 2022 (%)
Conventional Drug Delivery Formulations
Novel Drug Delivery Formulations
Long-acting Formulations
Global Injectable Drug Delivery Formulation Market, by Application, 2018-2023, 2024-2030 ($ Millions) & (K Pcs)
Global Injectable Drug Delivery Formulation Market Segment Percentages, by Application, 2022 (%)
Autoimmune Diseases
Hormonal Disorders
Oncology
Orphan Diseases
Others
Global Injectable Drug Delivery Formulation Market, By Region and Country, 2018-2023, 2024-2030 ($ Millions) & (K Pcs)
Global Injectable Drug Delivery Formulation Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Injectable Drug Delivery Formulation revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Injectable Drug Delivery Formulation revenues share in global market, 2022 (%)
Key companies Injectable Drug Delivery Formulation sales in global market, 2018-2023 (Estimated), (K Pcs)
Key companies Injectable Drug Delivery Formulation sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Becton, Dickinson and Company (US)
Baxter International Inc. (US)
Gerresheimer AG (Germany)
Pfizer, Inc. (US)
Schott AG (Germany)
Sandoz (Germany)
Teva Pharmaceutical Industries Ltd. (Israel)
Eli Lilly and Company (US)
Outline of Major Chapters:
Chapter 1: Introduces the definition of Injectable Drug Delivery Formulation, market overview.
Chapter 2: Global Injectable Drug Delivery Formulation market size in revenue and volume.
Chapter 3: Detailed analysis of Injectable Drug Delivery Formulation manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Injectable Drug Delivery Formulation in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Injectable Drug Delivery Formulation capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Injectable Drug Delivery Formulation Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Injectable Drug Delivery Formulation Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Injectable Drug Delivery Formulation Overall Market Size
2.1 Global Injectable Drug Delivery Formulation Market Size: 2022 VS 2030
2.2 Global Injectable Drug Delivery Formulation Revenue, Prospects & Forecasts: 2018-2030
2.3 Global Injectable Drug Delivery Formulation Sales: 2018-2030
3 Company Landscape
3.1 Top Injectable Drug Delivery Formulation Players in Global Market
3.2 Top Global Injectable Drug Delivery Formulation Companies Ranked by Revenue
3.3 Global Injectable Drug Delivery Formulation Revenue by Companies
3.4 Global Injectable Drug Delivery Formulation Sales by Companies
3.5 Global Injectable Drug Delivery Formulation Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Injectable Drug Delivery Formulation Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Injectable Drug Delivery Formulation Product Type
3.8 Tier 1, Tier 2 and Tier 3 Injectable Drug Delivery Formulation Players in Global Market
3.8.1 List of Global Tier 1 Injectable Drug Delivery Formulation Companies
3.8.2 List of Global Tier 2 and Tier 3 Injectable Drug Delivery Formulation Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Injectable Drug Delivery Formulation Market Size Markets, 2022 & 2030
4.1.2 Conventional Drug Delivery Formulations
4.1.3 Novel Drug Delivery Formulations
4.1.4 Long-acting Formulations
4.2 By Type - Global Injectable Drug Delivery Formulation Revenue & Forecasts
4.2.1 By Type - Global Injectable Drug Delivery Formulation Revenue, 2018-2023
4.2.2 By Type - Global Injectable Drug Delivery Formulation Revenue, 2024-2030
4.2.3 By Type - Global Injectable Drug Delivery Formulation Revenue Market Share, 2018-2030
4.3 By Type - Global Injectable Drug Delivery Formulation Sales & Forecasts
4.3.1 By Type - Global Injectable Drug Delivery Formulation Sales, 2018-2023
4.3.2 By Type - Global Injectable Drug Delivery Formulation Sales, 2024-2030
4.3.3 By Type - Global Injectable Drug Delivery Formulation Sales Market Share, 2018-2030
4.4 By Type - Global Injectable Drug Delivery Formulation Price (Manufacturers Selling Prices), 2018-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Injectable Drug Delivery Formulation Market Size, 2022 & 2030
5.1.2 Autoimmune Diseases
5.1.3 Hormonal Disorders
5.1.4 Oncology
5.1.5 Orphan Diseases
5.1.6 Others
5.2 By Application - Global Injectable Drug Delivery Formulation Revenue & Forecasts
5.2.1 By Application - Global Injectable Drug Delivery Formulation Revenue, 2018-2023
5.2.2 By Application - Global Injectable Drug Delivery Formulation Revenue, 2024-2030
5.2.3 By Application - Global Injectable Drug Delivery Formulation Revenue Market Share, 2018-2030
5.3 By Application - Global Injectable Drug Delivery Formulation Sales & Forecasts
5.3.1 By Application - Global Injectable Drug Delivery Formulation Sales, 2018-2023
5.3.2 By Application - Global Injectable Drug Delivery Formulation Sales, 2024-2030
5.3.3 By Application - Global Injectable Drug Delivery Formulation Sales Market Share, 2018-2030
5.4 By Application - Global Injectable Drug Delivery Formulation Price (Manufacturers Selling Prices), 2018-2030
6 Sights by Region
6.1 By Region - Global Injectable Drug Delivery Formulation Market Size, 2022 & 2030
6.2 By Region - Global Injectable Drug Delivery Formulation Revenue & Forecasts
6.2.1 By Region - Global Injectable Drug Delivery Formulation Revenue, 2018-2023
6.2.2 By Region - Global Injectable Drug Delivery Formulation Revenue, 2024-2030
6.2.3 By Region - Global Injectable Drug Delivery Formulation Revenue Market Share, 2018-2030
6.3 By Region - Global Injectable Drug Delivery Formulation Sales & Forecasts
6.3.1 By Region - Global Injectable Drug Delivery Formulation Sales, 2018-2023
6.3.2 By Region - Global Injectable Drug Delivery Formulation Sales, 2024-2030
6.3.3 By Region - Global Injectable Drug Delivery Formulation Sales Market Share, 2018-2030
6.4 North America
6.4.1 By Country - North America Injectable Drug Delivery Formulation Revenue, 2018-2030
6.4.2 By Country - North America Injectable Drug Delivery Formulation Sales, 2018-2030
6.4.3 US Injectable Drug Delivery Formulation Market Size, 2018-2030
6.4.4 Canada Injectable Drug Delivery Formulation Market Size, 2018-2030
6.4.5 Mexico Injectable Drug Delivery Formulation Market Size, 2018-2030
6.5 Europe
6.5.1 By Country - Europe Injectable Drug Delivery Formulation Revenue, 2018-2030
6.5.2 By Country - Europe Injectable Drug Delivery Formulation Sales, 2018-2030
6.5.3 Germany Injectable Drug Delivery Formulation Market Size, 2018-2030
6.5.4 France Injectable Drug Delivery Formulation Market Size, 2018-2030
6.5.5 U.K. Injectable Drug Delivery Formulation Market Size, 2018-2030
6.5.6 Italy Injectable Drug Delivery Formulation Market Size, 2018-2030
6.5.7 Russia Injectable Drug Delivery Formulation Market Size, 2018-2030
6.5.8 Nordic Countries Injectable Drug Delivery Formulation Market Size, 2018-2030
6.5.9 Benelux Injectable Drug Delivery Formulation Market Size, 2018-2030
6.6 Asia
6.6.1 By Region - Asia Injectable Drug Delivery Formulation Revenue, 2018-2030
6.6.2 By Region - Asia Injectable Drug Delivery Formulation Sales, 2018-2030
6.6.3 China Injectable Drug Delivery Formulation Market Size, 2018-2030
6.6.4 Japan Injectable Drug Delivery Formulation Market Size, 2018-2030
6.6.5 South Korea Injectable Drug Delivery Formulation Market Size, 2018-2030
6.6.6 Southeast Asia Injectable Drug Delivery Formulation Market Size, 2018-2030
6.6.7 India Injectable Drug Delivery Formulation Market Size, 2018-2030
6.7 South America
6.7.1 By Country - South America Injectable Drug Delivery Formulation Revenue, 2018-2030
6.7.2 By Country - South America Injectable Drug Delivery Formulation Sales, 2018-2030
6.7.3 Brazil Injectable Drug Delivery Formulation Market Size, 2018-2030
6.7.4 Argentina Injectable Drug Delivery Formulation Market Size, 2018-2030
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Injectable Drug Delivery Formulation Revenue, 2018-2030
6.8.2 By Country - Middle East & Africa Injectable Drug Delivery Formulation Sales, 2018-2030
6.8.3 Turkey Injectable Drug Delivery Formulation Market Size, 2018-2030
6.8.4 Israel Injectable Drug Delivery Formulation Market Size, 2018-2030
6.8.5 Saudi Arabia Injectable Drug Delivery Formulation Market Size, 2018-2030
6.8.6 UAE Injectable Drug Delivery Formulation Market Size, 2018-2030
7 Manufacturers & Brands Profiles
7.1 Becton, Dickinson and Company (US)
7.1.1 Becton, Dickinson and Company (US) Company Summary
7.1.2 Becton, Dickinson and Company (US) Business Overview
7.1.3 Becton, Dickinson and Company (US) Injectable Drug Delivery Formulation Major Product Offerings
7.1.4 Becton, Dickinson and Company (US) Injectable Drug Delivery Formulation Sales and Revenue in Global (2018-2023)
7.1.5 Becton, Dickinson and Company (US) Key News & Latest Developments
7.2 Baxter International Inc. (US)
7.2.1 Baxter International Inc. (US) Company Summary
7.2.2 Baxter International Inc. (US) Business Overview
7.2.3 Baxter International Inc. (US) Injectable Drug Delivery Formulation Major Product Offerings
7.2.4 Baxter International Inc. (US) Injectable Drug Delivery Formulation Sales and Revenue in Global (2018-2023)
7.2.5 Baxter International Inc. (US) Key News & Latest Developments
7.3 Gerresheimer AG (Germany)
7.3.1 Gerresheimer AG (Germany) Company Summary
7.3.2 Gerresheimer AG (Germany) Business Overview
7.3.3 Gerresheimer AG (Germany) Injectable Drug Delivery Formulation Major Product Offerings
7.3.4 Gerresheimer AG (Germany) Injectable Drug Delivery Formulation Sales and Revenue in Global (2018-2023)
7.3.5 Gerresheimer AG (Germany) Key News & Latest Developments
7.4 Pfizer, Inc. (US)
7.4.1 Pfizer, Inc. (US) Company Summary
7.4.2 Pfizer, Inc. (US) Business Overview
7.4.3 Pfizer, Inc. (US) Injectable Drug Delivery Formulation Major Product Offerings
7.4.4 Pfizer, Inc. (US) Injectable Drug Delivery Formulation Sales and Revenue in Global (2018-2023)
7.4.5 Pfizer, Inc. (US) Key News & Latest Developments
7.5 Schott AG (Germany)
7.5.1 Schott AG (Germany) Company Summary
7.5.2 Schott AG (Germany) Business Overview
7.5.3 Schott AG (Germany) Injectable Drug Delivery Formulation Major Product Offerings
7.5.4 Schott AG (Germany) Injectable Drug Delivery Formulation Sales and Revenue in Global (2018-2023)
7.5.5 Schott AG (Germany) Key News & Latest Developments
7.6 Sandoz (Germany)
7.6.1 Sandoz (Germany) Company Summary
7.6.2 Sandoz (Germany) Business Overview
7.6.3 Sandoz (Germany) Injectable Drug Delivery Formulation Major Product Offerings
7.6.4 Sandoz (Germany) Injectable Drug Delivery Formulation Sales and Revenue in Global (2018-2023)
7.6.5 Sandoz (Germany) Key News & Latest Developments
7.7 Teva Pharmaceutical Industries Ltd. (Israel)
7.7.1 Teva Pharmaceutical Industries Ltd. (Israel) Company Summary
7.7.2 Teva Pharmaceutical Industries Ltd. (Israel) Business Overview
7.7.3 Teva Pharmaceutical Industries Ltd. (Israel) Injectable Drug Delivery Formulation Major Product Offerings
7.7.4 Teva Pharmaceutical Industries Ltd. (Israel) Injectable Drug Delivery Formulation Sales and Revenue in Global (2018-2023)
7.7.5 Teva Pharmaceutical Industries Ltd. (Israel) Key News & Latest Developments
7.8 Eli Lilly and Company (US)
7.8.1 Eli Lilly and Company (US) Company Summary
7.8.2 Eli Lilly and Company (US) Business Overview
7.8.3 Eli Lilly and Company (US) Injectable Drug Delivery Formulation Major Product Offerings
7.8.4 Eli Lilly and Company (US) Injectable Drug Delivery Formulation Sales and Revenue in Global (2018-2023)
7.8.5 Eli Lilly and Company (US) Key News & Latest Developments
8 Global Injectable Drug Delivery Formulation Production Capacity, Analysis
8.1 Global Injectable Drug Delivery Formulation Production Capacity, 2018-2030
8.2 Injectable Drug Delivery Formulation Production Capacity of Key Manufacturers in Global Market
8.3 Global Injectable Drug Delivery Formulation Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Injectable Drug Delivery Formulation Supply Chain Analysis
10.1 Injectable Drug Delivery Formulation Industry Value Chain
10.2 Injectable Drug Delivery Formulation Upstream Market
10.3 Injectable Drug Delivery Formulation Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Injectable Drug Delivery Formulation Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Key Players of Injectable Drug Delivery Formulation in Global Market
Table 2. Top Injectable Drug Delivery Formulation Players in Global Market, Ranking by Revenue (2022)
Table 3. Global Injectable Drug Delivery Formulation Revenue by Companies, (US$, Mn), 2018-2023
Table 4. Global Injectable Drug Delivery Formulation Revenue Share by Companies, 2018-2023
Table 5. Global Injectable Drug Delivery Formulation Sales by Companies, (K Pcs), 2018-2023
Table 6. Global Injectable Drug Delivery Formulation Sales Share by Companies, 2018-2023
Table 7. Key Manufacturers Injectable Drug Delivery Formulation Price (2018-2023) & (USD/Pcs)
Table 8. Global Manufacturers Injectable Drug Delivery Formulation Product Type
Table 9. List of Global Tier 1 Injectable Drug Delivery Formulation Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Injectable Drug Delivery Formulation Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Injectable Drug Delivery Formulation Revenue, (US$, Mn), 2022 & 2030
Table 12. By Type - Global Injectable Drug Delivery Formulation Revenue (US$, Mn), 2018-2023
Table 13. By Type - Global Injectable Drug Delivery Formulation Revenue (US$, Mn), 2024-2030
Table 14. By Type - Global Injectable Drug Delivery Formulation Sales (K Pcs), 2018-2023
Table 15. By Type - Global Injectable Drug Delivery Formulation Sales (K Pcs), 2024-2030
Table 16. By Application ? Global Injectable Drug Delivery Formulation Revenue, (US$, Mn), 2022 & 2030
Table 17. By Application - Global Injectable Drug Delivery Formulation Revenue (US$, Mn), 2018-2023
Table 18. By Application - Global Injectable Drug Delivery Formulation Revenue (US$, Mn), 2024-2030
Table 19. By Application - Global Injectable Drug Delivery Formulation Sales (K Pcs), 2018-2023
Table 20. By Application - Global Injectable Drug Delivery Formulation Sales (K Pcs), 2024-2030
Table 21. By Region ? Global Injectable Drug Delivery Formulation Revenue, (US$, Mn), 2022 VS 2030
Table 22. By Region - Global Injectable Drug Delivery Formulation Revenue (US$, Mn), 2018-2023
Table 23. By Region - Global Injectable Drug Delivery Formulation Revenue (US$, Mn), 2024-2030
Table 24. By Region - Global Injectable Drug Delivery Formulation Sales (K Pcs), 2018-2023
Table 25. By Region - Global Injectable Drug Delivery Formulation Sales (K Pcs), 2024-2030
Table 26. By Country - North America Injectable Drug Delivery Formulation Revenue, (US$, Mn), 2018-2023
Table 27. By Country - North America Injectable Drug Delivery Formulation Revenue, (US$, Mn), 2024-2030
Table 28. By Country - North America Injectable Drug Delivery Formulation Sales, (K Pcs), 2018-2023
Table 29. By Country - North America Injectable Drug Delivery Formulation Sales, (K Pcs), 2024-2030
Table 30. By Country - Europe Injectable Drug Delivery Formulation Revenue, (US$, Mn), 2018-2023
Table 31. By Country - Europe Injectable Drug Delivery Formulation Revenue, (US$, Mn), 2024-2030
Table 32. By Country - Europe Injectable Drug Delivery Formulation Sales, (K Pcs), 2018-2023
Table 33. By Country - Europe Injectable Drug Delivery Formulation Sales, (K Pcs), 2024-2030
Table 34. By Region - Asia Injectable Drug Delivery Formulation Revenue, (US$, Mn), 2018-2023
Table 35. By Region - Asia Injectable Drug Delivery Formulation Revenue, (US$, Mn), 2024-2030
Table 36. By Region - Asia Injectable Drug Delivery Formulation Sales, (K Pcs), 2018-2023
Table 37. By Region - Asia Injectable Drug Delivery Formulation Sales, (K Pcs), 2024-2030
Table 38. By Country - South America Injectable Drug Delivery Formulation Revenue, (US$, Mn), 2018-2023
Table 39. By Country - South America Injectable Drug Delivery Formulation Revenue, (US$, Mn), 2024-2030
Table 40. By Country - South America Injectable Drug Delivery Formulation Sales, (K Pcs), 2018-2023
Table 41. By Country - South America Injectable Drug Delivery Formulation Sales, (K Pcs), 2024-2030
Table 42. By Country - Middle East & Africa Injectable Drug Delivery Formulation Revenue, (US$, Mn), 2018-2023
Table 43. By Country - Middle East & Africa Injectable Drug Delivery Formulation Revenue, (US$, Mn), 2024-2030
Table 44. By Country - Middle East & Africa Injectable Drug Delivery Formulation Sales, (K Pcs), 2018-2023
Table 45. By Country - Middle East & Africa Injectable Drug Delivery Formulation Sales, (K Pcs), 2024-2030
Table 46. Becton, Dickinson and Company (US) Company Summary
Table 47. Becton, Dickinson and Company (US) Injectable Drug Delivery Formulation Product Offerings
Table 48. Becton, Dickinson and Company (US) Injectable Drug Delivery Formulation Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2018-2023)
Table 49. Becton, Dickinson and Company (US) Key News & Latest Developments
Table 50. Baxter International Inc. (US) Company Summary
Table 51. Baxter International Inc. (US) Injectable Drug Delivery Formulation Product Offerings
Table 52. Baxter International Inc. (US) Injectable Drug Delivery Formulation Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2018-2023)
Table 53. Baxter International Inc. (US) Key News & Latest Developments
Table 54. Gerresheimer AG (Germany) Company Summary
Table 55. Gerresheimer AG (Germany) Injectable Drug Delivery Formulation Product Offerings
Table 56. Gerresheimer AG (Germany) Injectable Drug Delivery Formulation Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2018-2023)
Table 57. Gerresheimer AG (Germany) Key News & Latest Developments
Table 58. Pfizer, Inc. (US) Company Summary
Table 59. Pfizer, Inc. (US) Injectable Drug Delivery Formulation Product Offerings
Table 60. Pfizer, Inc. (US) Injectable Drug Delivery Formulation Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2018-2023)
Table 61. Pfizer, Inc. (US) Key News & Latest Developments
Table 62. Schott AG (Germany) Company Summary
Table 63. Schott AG (Germany) Injectable Drug Delivery Formulation Product Offerings
Table 64. Schott AG (Germany) Injectable Drug Delivery Formulation Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2018-2023)
Table 65. Schott AG (Germany) Key News & Latest Developments
Table 66. Sandoz (Germany) Company Summary
Table 67. Sandoz (Germany) Injectable Drug Delivery Formulation Product Offerings
Table 68. Sandoz (Germany) Injectable Drug Delivery Formulation Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2018-2023)
Table 69. Sandoz (Germany) Key News & Latest Developments
Table 70. Teva Pharmaceutical Industries Ltd. (Israel) Company Summary
Table 71. Teva Pharmaceutical Industries Ltd. (Israel) Injectable Drug Delivery Formulation Product Offerings
Table 72. Teva Pharmaceutical Industries Ltd. (Israel) Injectable Drug Delivery Formulation Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2018-2023)
Table 73. Teva Pharmaceutical Industries Ltd. (Israel) Key News & Latest Developments
Table 74. Eli Lilly and Company (US) Company Summary
Table 75. Eli Lilly and Company (US) Injectable Drug Delivery Formulation Product Offerings
Table 76. Eli Lilly and Company (US) Injectable Drug Delivery Formulation Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2018-2023)
Table 77. Eli Lilly and Company (US) Key News & Latest Developments
Table 78. Injectable Drug Delivery Formulation Production Capacity (K Pcs) of Key Manufacturers in Global Market, 2021-2023 (K Pcs)
Table 79. Global Injectable Drug Delivery Formulation Capacity Market Share of Key Manufacturers, 2021-2023
Table 80. Global Injectable Drug Delivery Formulation Production by Region, 2018-2023 (K Pcs)
Table 81. Global Injectable Drug Delivery Formulation Production by Region, 2024-2030 (K Pcs)
Table 82. Injectable Drug Delivery Formulation Market Opportunities & Trends in Global Market
Table 83. Injectable Drug Delivery Formulation Market Drivers in Global Market
Table 84. Injectable Drug Delivery Formulation Market Restraints in Global Market
Table 85. Injectable Drug Delivery Formulation Raw Materials
Table 86. Injectable Drug Delivery Formulation Raw Materials Suppliers in Global Market
Table 87. Typical Injectable Drug Delivery Formulation Downstream
Table 88. Injectable Drug Delivery Formulation Downstream Clients in Global Market
Table 89. Injectable Drug Delivery Formulation Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Injectable Drug Delivery Formulation Segment by Type in 2022
Figure 2. Injectable Drug Delivery Formulation Segment by Application in 2022
Figure 3. Global Injectable Drug Delivery Formulation Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Injectable Drug Delivery Formulation Market Size: 2022 VS 2030 (US$, Mn)
Figure 6. Global Injectable Drug Delivery Formulation Revenue, 2018-2030 (US$, Mn)
Figure 7. Injectable Drug Delivery Formulation Sales in Global Market: 2018-2030 (K Pcs)
Figure 8. The Top 3 and 5 Players Market Share by Injectable Drug Delivery Formulation Revenue in 2022
Figure 9. By Type - Global Injectable Drug Delivery Formulation Revenue, (US$, Mn), 2022 & 2030
Figure 10. By Type - Global Injectable Drug Delivery Formulation Revenue Market Share, 2018-2030
Figure 11. By Type - Global Injectable Drug Delivery Formulation Sales Market Share, 2018-2030
Figure 12. By Type - Global Injectable Drug Delivery Formulation Price (USD/Pcs), 2018-2030
Figure 13. By Application - Global Injectable Drug Delivery Formulation Revenue, (US$, Mn), 2022 & 2030
Figure 14. By Application - Global Injectable Drug Delivery Formulation Revenue Market Share, 2018-2030
Figure 15. By Application - Global Injectable Drug Delivery Formulation Sales Market Share, 2018-2030
Figure 16. By Application - Global Injectable Drug Delivery Formulation Price (USD/Pcs), 2018-2030
Figure 17. By Region - Global Injectable Drug Delivery Formulation Revenue, (US$, Mn), 2022 & 2030
Figure 18. By Region - Global Injectable Drug Delivery Formulation Revenue Market Share, 2018 VS 2022 VS 2030
Figure 19. By Region - Global Injectable Drug Delivery Formulation Revenue Market Share, 2018-2030
Figure 20. By Region - Global Injectable Drug Delivery Formulation Sales Market Share, 2018-2030
Figure 21. By Country - North America Injectable Drug Delivery Formulation Revenue Market Share, 2018-2030
Figure 22. By Country - North America Injectable Drug Delivery Formulation Sales Market Share, 2018-2030
Figure 23. US Injectable Drug Delivery Formulation Revenue, (US$, Mn), 2018-2030
Figure 24. Canada Injectable Drug Delivery Formulation Revenue, (US$, Mn), 2018-2030
Figure 25. Mexico Injectable Drug Delivery Formulation Revenue, (US$, Mn), 2018-2030
Figure 26. By Country - Europe Injectable Drug Delivery Formulation Revenue Market Share, 2018-2030
Figure 27. By Country - Europe Injectable Drug Delivery Formulation Sales Market Share, 2018-2030
Figure 28. Germany Injectable Drug Delivery Formulation Revenue, (US$, Mn), 2018-2030
Figure 29. France Injectable Drug Delivery Formulation Revenue, (US$, Mn), 2018-2030
Figure 30. U.K. Injectable Drug Delivery Formulation Revenue, (US$, Mn), 2018-2030
Figure 31. Italy Injectable Drug Delivery Formulation Revenue, (US$, Mn), 2018-2030
Figure 32. Russia Injectable Drug Delivery Formulation Revenue, (US$, Mn), 2018-2030
Figure 33. Nordic Countries Injectable Drug Delivery Formulation Revenue, (US$, Mn), 2018-2030
Figure 34. Benelux Injectable Drug Delivery Formulation Revenue, (US$, Mn), 2018-2030
Figure 35. By Region - Asia Injectable Drug Delivery Formulation Revenue Market Share, 2018-2030
Figure 36. By Region - Asia Injectable Drug Delivery Formulation Sales Market Share, 2018-2030
Figure 37. China Injectable Drug Delivery Formulation Revenue, (US$, Mn), 2018-2030
Figure 38. Japan Injectable Drug Delivery Formulation Revenue, (US$, Mn), 2018-2030
Figure 39. South Korea Injectable Drug Delivery Formulation Revenue, (US$, Mn), 2018-2030
Figure 40. Southeast Asia Injectable Drug Delivery Formulation Revenue, (US$, Mn), 2018-2030
Figure 41. India Injectable Drug Delivery Formulation Revenue, (US$, Mn), 2018-2030
Figure 42. By Country - South America Injectable Drug Delivery Formulation Revenue Market Share, 2018-2030
Figure 43. By Country - South America Injectable Drug Delivery Formulation Sales Market Share, 2018-2030
Figure 44. Brazil Injectable Drug Delivery Formulation Revenue, (US$, Mn), 2018-2030
Figure 45. Argentina Injectable Drug Delivery Formulation Revenue, (US$, Mn), 2018-2030
Figure 46. By Country - Middle East & Africa Injectable Drug Delivery Formulation Revenue Market Share, 2018-2030
Figure 47. By Country - Middle East & Africa Injectable Drug Delivery Formulation Sales Market Share, 2018-2030
Figure 48. Turkey Injectable Drug Delivery Formulation Revenue, (US$, Mn), 2018-2030
Figure 49. Israel Injectable Drug Delivery Formulation Revenue, (US$, Mn), 2018-2030
Figure 50. Saudi Arabia Injectable Drug Delivery Formulation Revenue, (US$, Mn), 2018-2030
Figure 51. UAE Injectable Drug Delivery Formulation Revenue, (US$, Mn), 2018-2030
Figure 52. Global Injectable Drug Delivery Formulation Production Capacity (K Pcs), 2018-2030
Figure 53. The Percentage of Production Injectable Drug Delivery Formulation by Region, 2022 VS 2030
Figure 54. Injectable Drug Delivery Formulation Industry Value Chain
Figure 55. Marketing Channels
